A fatal demyelinating illness in a young woman 10 weeks post partum

Lancet Neurology

Volumn 4, Issue 2, 2005, Pages 129-134

  Koch, Marcus ^a   Den Dunnen, Wilfred ^a   Sie, Onggie G ^a   De Keyser, Jacques ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HALOPERIDOL; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ADULT; ARTICLE; BEHCET DISEASE; BRAIN INFECTION; CASE REPORT; DEATH; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; FEMALE; HUMAN; LEUKOENCEPHALOPATHY; LYMPHOMATOSIS; MELAS SYNDROME; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; POSTVACCINAL ENCEPHALITIS; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SARCOIDOSIS; VASCULITIS;

EID: 12344257977     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)00994-4     Document Type: Review

References (43)

1. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. 339:1998;285-291
2. Stuve O, Zamvil SS. Pathogenesis, diagnosis, and treatment of acute disseminated encephalomyelitis. Curr Opin Neurol. 12:1999;395-401
3. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 56:2001;1308-1312
4. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 56:2001;1313-1318
5. McLean BN, Luxton RW, Thompson EJ. A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index: a comparison and diagnostic applications. Brain. 113:1990;1269-1289
6. Hartung HP, Grossman RI. ADEM: distinct disease or part of the MS spectrum? Neurology. 56:2001;1257-1260
7. Murthy SN, Faden HS, Cohen ME, Bakshi R. Acute disseminated encephalomyelitis in children. Pediatrics. 110:2002;e21
8. Kuperan S, Ostrow P, Landi MK, Bakshi R. Acute hemorrhagic leukoencephalitis vs ADEM: FLAIR MRI and neuropathology findings. Neurology. 60:2003;721-722
9. Masuhr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. J Neurol. 251:2004;11-23
10. Siva A. Vasculitis of the nervous system. J Neurol. 248:2001;451-468
11. Younger DS. Vasculitis of the nervous system. Curr Opin Neurol. 17:2004;317-336
12. Moore PM, Richardson B. Neurology of the vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry. 65:1998;10-22
13. Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behcet's disease: evaluation of 200 patients. Brain. 122:1999;2171-2182
14. Siva A, Kantarci OH, Saip S, et al. Behcet's disease: diagnostic and prognostic aspects of neurological involvement. J Neurol. 248:2001;95-103
15. Siva A, Altintas A, Saip S. Behcet's syndrome and the nervous system. Curr Opin Neurol. 17:2004;347-357
16. Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol. 61:2004;411-416
17. Martin-Duverneuil N, Mokhtari K, Behin A, Lafitte F, Hoang-Xuan K, Chiras J. Intravascular malignant lymphomatosis. Neuroradiology. 44:2002;749-754
18. Williams RL, Meltzer CC, Smirniotopoulos JG, Fukui MB, Inman M. Cerebral MR imaging in intravascular lymphomatosis. AJNR Am J Neuroradiol. 19:1998;427-431
19. Beristain X, Azzarelli B. The neurological masquerade of intravascular lymphomatosis. Arch Neurol. 59:2002;439-443
20. Simon DK, Johns DR. Mitochondrial disorders: clinical and genetic features. Annu Rev Med. 50:1999;111-127
21. Abe K, Yoshimura H, Tanaka H, Fujita N, Hikita T, Sakoda S. Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events. Neuroradiology. 46:2004;113-117
22. Gullapalli D, Phillips LH. Neurologic manifestations of sarcoidosis. Neurol Clin. 20:2002;59-83
23. Burns TM. Neurosarcoidosis. Arch Neurol. 60:2003;1166-1168
24. Crystal R. Sarcoidosis. Kasper D, Braunwald E, Fauci A, Hauser S, Longo D, Jameson J. Harrison's principles of internal medicine. 2004;2017-2024 McGraw-Hill, New York
25. Koralnik IJ. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol. 17:2004;365-370
26. Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology. 187:1993;233-240
27. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet. 352:1998;557-565
28. Gilden DH. Varicella zoster virus vasculopathy and disseminated encephalomyelitis. J Neurol Sci. 195:2002;99-101
29. Gilden DH, Mahalingam R, Cohrs RJ, Kleinschmidt-DeMasters BK, Forghani B. The protean manifestations of varicella-zoster virus vasculopathy. J Neurovirol. 8:(suppl 2):2002;75-79
30. Berger JR, Tornatore C, Major EO, et al. Relapsing and remitting human immunodeficiency virus-associated leukoencephalomyelopathy. Ann Neurol. 31:1992;34-38
31. Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med. 345:2001;425-432
32. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol. 55:2004;458-468
33. Martino G, Hartung HP. Immunopathogenesis of multiple sclerosis: the role of T cells. Curr Opin Neurol. 12:1999;309-321
34. Burns J, Rosenzweig A, Zweiman B, Lisak RP. Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell Immunol. 81:1983;435-440
35. Ozenci V, Kouwenhoven M, Link H. Cytokines in multiple sclerosis: methodological aspects and pathogenic implications. Mult Scler. 8:2002;396-404
36. Yoshitomi T, Matsubara T, Nishikawa M, et al. Increased peripheral blood interferon gamma-producing T cells in acute disseminated encephalomyelitis. J Neuroimmunol. 111:2000;224-228
37. Kadhim H, De Prez C, Gazagnes MD, Sebire G. In situ cytokine immune responses in acute disseminated encephalomyelitis: insights into pathophysiologic mechanisms. Hum Pathol. 34:2003;293-297
38. Rudolf S, Peters M, Rothermundt M, Arolt V, Kirchner H. The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interferon-gamma in vitro. Neuropsychobiology. 46:2002;180-185
39. Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology. 54:2000;1370-1372
40. Marchioni E, Marinou-Aktipi K, Uggetti C, et al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroid-resistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol. 249:2002;100-104
41. Kanter DS, Horensky D, Sperling RA, Kaplan JD, Malachowski ME, Churchill WH Jr. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology. 45:1995;824-827
42. Noseworthy JH. Treatment of multiple sclerosis and related disorders: what's new in the past 2 years? Clin Neuropharmacol. 26:2003;28-37
43. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology. 59:2002;1224-1231